CD20-Positive Lymphoid Malignancies
1 clinical trials · Condition
◉ Watch CD20-Positive Lymphoid Malignancies
| Record | Firm | Date |
|---|---|---|
| Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers (NCT00788684) | AbbVie | 2009-07-21 |
Track CD20-Positive Lymphoid Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.